Ocaperidone 50 mg | 99.94%
TargetMol
Ocaperidona (Ocaperidone), a very high affinity dopamine D2 antagonist.
More Information Supplier PageOcaperidone
Search Results
Ocaperidone 25 mg | 99.94%
TargetMol
Ocaperidona (Ocaperidone), a very high affinity dopamine D2 antagonist.
More Information Supplier PageOcaperidone
Valrocemide 50 mg | 99.90%
TargetMol
Valrocemide, also known as TV-1901, is an antiepileptic drug (AED). Valrocemide has a broad spectrum of anticonvulsant activity and promising potential as a new AED. Valrocemide is an anticonvulsant agent under development by Teva and Acorda as a potential therapeutic for the treatment of epilepsy.
More Information Supplier PageValrocemide
Valrocemide 5 mg | 99.90%
TargetMol
Valrocemide, also known as TV-1901, is an antiepileptic drug (AED). Valrocemide has a broad spectrum of anticonvulsant activity and promising potential as a new AED. Valrocemide is an anticonvulsant agent under development by Teva and Acorda as a potential therapeutic for the treatment of epilepsy.
More Information Supplier PageValrocemide
Sodium dichloroacetate 50 mg | 98.17%
TargetMol
Dichloroacetate, a specific inhibitor of pyruvate dehydrogenase kinase (PDK) with IC50 values of 183 and 80 μM for PDK2 and PDK4 respectively, has been shown to derepress a mitochondrial potassium-ion channel axis, trigger apoptosis in cancer cells, and inhibit tumor growth.
More Information Supplier PageSodium dichloroacetate
Sodium dichloroacetate 200 mg | 98.17%
TargetMol
Dichloroacetate, a specific inhibitor of pyruvate dehydrogenase kinase (PDK) with IC50 values of 183 and 80 μM for PDK2 and PDK4 respectively, has been shown to derepress a mitochondrial potassium-ion channel axis, trigger apoptosis in cancer cells, and inhibit tumor growth.
More Information Supplier PageSodium dichloroacetate 100 mg | 98.17%
TargetMol
Dichloroacetate, a specific inhibitor of pyruvate dehydrogenase kinase (PDK) with IC50 values of 183 and 80 μM for PDK2 and PDK4 respectively, has been shown to derepress a mitochondrial potassium-ion channel axis, trigger apoptosis in cancer cells, and inhibit tumor growth.
More Information Supplier PageSodium dichloroacetate
NSC23005 5 mg | Purity Not Available
TargetMol
NSC23005 sodium is a p18INK inhibitor with potently promoted hematopoietic stem cell (HSC) expansion (ED50: 5.21 nM).
More Information Supplier PageNSC23005
NSC23005 50 mg | Purity Not Available
TargetMol
NSC23005 sodium is a p18INK inhibitor with potently promoted hematopoietic stem cell (HSC) expansion (ED50: 5.21 nM).
More Information Supplier PageNSC23005
NSC23005 25 mg | Purity Not Available
TargetMol
NSC23005 sodium is a p18INK inhibitor with potently promoted hematopoietic stem cell (HSC) expansion (ED50: 5.21 nM).
More Information Supplier PageNSC23005